People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Specialized Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $1.6M | $7.5M | 2009 |
| QoL meds, LLC | — | Pharmaceuticals | Seed | $1.1M | $41.8M | 2009 |
Michael Huffer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Huffer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James F. Smith | 2 | 5 |
| Charles Schellhorn | 2 | 4 |
| Daniel Sassano | 2 | 3 |
| MICHAEL K MCMAHAN | 2 | 3 |
| Francois Bitz | 2 | 2 |
| DAVID K ROBB | 2 | 2 |
| Larry Bowman | 1 | 2 |
| Richard F. Rizzo | 1 | 2 |
| RICHARD RIZZO | 1 | 1 |
| FRANCOIS K BITZ | 1 | 1 |
| DANIEL F SASSANO | 1 | 1 |
| CHARLES K SCHELLHORN | 1 | 1 |
| MICHAEL F HUFFER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.